| Similar Articles |
|---|
 |
The Motley Fool
August 26, 2011
Ilan Moscovitz |
Priceline.com Is Better Than You Think Like peers Orbitz and Travelzoo, Priceline tends to generate more free cash flow than net income, suggesting that the company might be more profitable -- and its stock cheaper -- than many investors realize.   |
The Motley Fool
August 25, 2011
Ilan Moscovitz |
InterDigital Is Better Than You Think InterDigital tends to generate more free cash flow than net income, suggesting that the company's stock might be a bit cheaper than many investors realize. |
The Motley Fool
August 25, 2011
Ilan Moscovitz |
Paychex Is Better Than You Think Like many of its peers, Paychex tends to generate more free cash flow than net income, suggesting that the company's stock might be a bit cheaper than many investors realize. |
The Motley Fool
August 23, 2011
Ilan Moscovitz |
Transocean Is Better Than You Think Transocean recently has tended to generate much more free cash flow than net income, suggesting that the company's stock might be a bit cheaper than many investors realize. |
The Motley Fool
March 3, 2011
Ilan Moscovitz |
Amazon.com May Be Cheaper Than You Think Amazon.com has a tendency to produce more free cash flow than net income. This means that the standard price-to-earnings multiple investors use to judge companies may overstate its price tag. |
The Motley Fool
August 17, 2011
Ilan Moscovitz |
Frontier Communications Is Cheaper Than You Think Let's examine Frontier alongside some of its peers for additional context. |
The Motley Fool
August 19, 2011
Ilan Moscovitz |
Xerox Is Cheaper Than You Think Xerox tends to generate substantially more free cash flow than net income, suggesting that the company's stock might be a quite a bit cheaper than its peers -- and many investors -- realize. |
The Motley Fool
August 25, 2011
Ilan Moscovitz |
Activision Blizzard Is Better Than You Think While Activision Blizzard looks moderately priced on a net income basis, it -- like some of its video game peers -- tends to generate more free cash flow than net income, suggesting that the company's stock might quite a bit cheaper than many investors realize. |
The Motley Fool
March 3, 2011
Ilan Moscovitz |
Republic Services May Be Cheaper Than You Think Here's why. |
The Motley Fool
August 28, 2011
Ilan Moscovitz |
Sirius XM Radio Is Even Better Than You Think Here's why. |
The Motley Fool
August 17, 2011
Ilan Moscovitz |
Pfizer Is Cheaper Than You Think Let's examine Pfizer alongside some of its peers for additional context. |
The Motley Fool
March 8, 2005
Seth Jayson |
Rite Aid Wretched? Value investors may be interested in Rite Aid. |
The Motley Fool
August 31, 2010
Ilan Moscovitz |
Why Apple Is Cheaper Than You Think It just might be. |
The Motley Fool
August 30, 2010
Ilan Moscovitz |
Why Sirius XM May Be Cheaper Than You Think It just might be. |
The Motley Fool
September 9, 2010
Ilan Moscovitz |
Oracle Is Cheaper Than You Think Oracle's free cash flow multiple suggests it is much cheaper than many investors think. |
The Motley Fool
August 31, 2010
Ilan Moscovitz |
Why Vonage Is Cheaper Than You Think It just might be. |
The Motley Fool
January 4, 2005
Seth Jayson |
Rite Aid Still Needs First Aid Sales keep slacking for this tough turnaround. This doesn't mean investors should necessarily jump ship. |
The Motley Fool
October 4, 2005
Seth Jayson |
Same Old Same-Store Story Reports from Walgreen and Rite Aid confirm the obvious. Investors will nearly always do better buying the best company in any given space. |
The Motley Fool
April 11, 2008
Ryan Fuhrmann |
Rite Aid Hasn't Fully Recovered Rite Aid needs to be nursed back to health after its acquisition of Brooks Eckerd. |
The Motley Fool
April 13, 2007
Ryan Fuhrmann |
Rite Aid's Right-Size Ambitions If the retail pharmacy chain can improve its net margins, reduce debt, and smoothly integrate its latest acquisition, the stock's upside would be substantial. |
The Motley Fool
June 21, 2006
Rich Smith |
Foolish Forecast: Rite Aid Revival? Will tomorrow's earnings news make it three bad quarters in a row for the retail pharmacy? Investors, take note. |
The Motley Fool
July 6, 2004
Alyce Lomax |
Not Ready for Rite Aid Can the drugstore chain hold a candle to the competition? Its shares are trading at 22 times forward earnings, making it a seemingly less-than-advantageous time to place a bet on them. |
The Motley Fool
June 27, 2011
Shubh Datta |
All Is Not Yet Right at Rite Aid Drug retailer Rite Aid posts losses in its first fiscal quarter and sees further losses ahead. |
The Motley Fool
June 29, 2007
Ryan Fuhrmann |
Rite Aid's Recent Remedy Will increased market clout lead the drugstore operator to new highs? Investors, take note. |
The Motley Fool
January 5, 2007
Matthew Crews |
Rite Aid's Baby Steps If Rite Aid does manage 5% operating margins, this pharmacy chain's shares will get the love they deserve. |
The Motley Fool
August 31, 2010
Ilan Moscovitz |
Las Vegas Sands May Be Cheaper Than You Think If Sands ever manages to cut back on the whopping costs of growing its business, we could see a spike in free cash flow. |
The Motley Fool
September 29, 2011
Navjot Kaur |
Should You Write Off Rite Aid? Rite Aid posts a relatively better quarter as wellness rewards the company. |
The Motley Fool
September 29, 2011
Dan Caplinger |
Has Rite Aid Become the Perfect Stock? The company needs to turn itself around first before anyone will seriously expect superior results from Rite Aid. |
The Motley Fool
December 11, 2006
Matthew Crews |
Rite Aid: Comps Mean Competition The pharmacy chain reported positive same-store results for November. Investors, take note. |
The Motley Fool
June 11, 2007
Mike Cianciolo |
Rite Aid's Generic Sales The drugstore chain gradually increases sales, and catches up to the big boys in one way. Investors, take note. |
The Motley Fool
September 22, 2010
Rich Smith |
Foolish Forecast: A Prescription for Rite Aid Investors Here's what you need to know before earnings come out tomorrow. |
The Motley Fool
September 25, 2009
Chris Jones |
The First Symptom of Health-Care Troubles? Rite Aid's problems imply bad news for consumers and the health-care system. |
The Motley Fool
September 26, 2007
Ryan Fuhrmann |
Foolish Forecast: Does Rite Aid Have the Right Rx? The retail pharmacy is set to release it second-quarter financial results. Investors, here is what you can expect to see. |
The Motley Fool
November 23, 2008
Todd Wenning |
A Value Stock to Avoid in This Market Rite Aid is one "value" to avoid in this market. |
The Motley Fool
September 22, 2006
Ryan Fuhrmann |
More in Store at Rite Aid? The retail pharmacy posted strong second-quarter sales, and an acquisition could help long-term results. Investors, take note. |
The Motley Fool
June 25, 2004
Steven Mallas |
Rite Aid in the Shadows The first quarter for Rite Aid, the pharmaceutical retailer, shows a profit, but is it time to add this stock to your portfolio? |
The Motley Fool
January 4, 2008
Timothy M. Otte |
Drugstore Sales Droop in December The three major drugstore chains, Walgreen, CVS, and Rite Aid, all report soft sales for December. |
The Motley Fool
January 3, 2012
Shubh Datta |
Bright Spots for Rite Aid Better same-store sales help Rite Aid trim losses. |
The Motley Fool
June 25, 2007
Ryan Fuhrmann |
Foolish Forecast: Rite Aid Aims for Healthy Growth The drugstore operator is set to report its first-quarter earnings. Investors, here is what you can expect to see. |
The Motley Fool
September 22, 2005
Stephen D. Simpson |
Rite Aid Not Right Yet The bleeding seems to have stopped at this pharmacy, but recovery could be a long and slow road. Intrepid, not to mention patient, investors may see potential here, but there are far better turnaround ideas to be had. |
The Motley Fool
September 27, 2007
Ryan Fuhrmann |
Rite Aid Looks a Little Peaked Bigger doesn't necessarily mean better for the drugstore retailer; it has quite a bit of work to do to convince investors it can successfully manage the empire that it has acquired. |
The Motley Fool
June 24, 2005
Stephen D. Simpson |
Is Rite Aid a Real Value Stock? Reality hasn't caught up with the company's turnaround prospects. Rite Aid must deal with a lot of debt and preferred equity if and when it recovers. |
The Motley Fool
April 8, 2004
Seth Jayson |
Rite Aid Wrings Out Profits Net store closings and comps increases bring black ink to the pharmacy's bottom line. |
The Motley Fool
September 24, 2004
Seth Jayson |
Kick This Drug Habit Rite Aid offers slow sales and minuscule shareholder rewards. |
The Motley Fool
October 21, 2010
Anand Chokkavelu |
9 Basic Stocks Near 52-Week Lows Here are the largest food and staples stocks by market cap that are hugging 52-week lows: Wal-Mart... CVS... Costco... SYSCO... Kroger... Companhia Brasileira... Safeway... Delhaize... Rite Aid... |
The Motley Fool
June 14, 2010
Rich Smith |
Is CVS' $2 Billion Buyback Good Medicine? Don't assume just because CVS is buying its stock, that this is a good idea. |
The Motley Fool
September 7, 2004
Seth Jayson |
Rejecting Rite Aid Shares of the drugstore chain droped 13%, and may prove to be a bargain if this is indeed a temporary slowdown and management can deliver more robust growth. |
The Motley Fool
December 19, 2011
Seth Jayson |
Golf Clap for Rite Aid Rite Aid reported revenue of $6.3 billion. The five analysts polled by S&P Capital IQ looked for revenue of $6.3 billion. |
The Motley Fool
September 14, 2006
Ryan Fuhrmann |
Playing Defense With the Drugstore Industry Retail pharmacy August sales trends help investors discern the leader in this appealing sector. |
The Motley Fool
April 5, 2006
Rich Smith |
Foolish Forecast: Rite Aid Writes a Script Although the retail pharmacy isn't setting the world on fire with its turnaround, its gross margins have inched up slightly over the last 18 months. Investors, take note. |
